Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Lixia Zhang, PhD

Staff Fellow
FDA

Dr. Lixia Zhang is a key member of the Innovation and Partnership Program within the Office of Clinical Pharmacology (OCP) at FDA. She specializes in Artificial Intelligence/Machine Learning (AI/ML), Real-World Evidence (RWE), and omics data. Dr. Zhang has made significant contributions to several New Drug Application (NDA) reviews, particularly in assessing the reliability of AI/ML and RWD/RWE components used in clinical trials and drug development. Beyond her review duties, Dr. Zhang is instrumental in co-leading research initiatives aimed at exploiting RWD, omics data, and innovative methodologies to drive advancements in precision medicine.

Disclosure(s): No financial relationships to disclose

Presentation(s):